- Report
- February 2024
- 135 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Relpax is a brand of analgesic drug used to treat migraine headaches. It belongs to a class of drugs known as triptans, which are selective serotonin receptor agonists. Relpax works by narrowing the blood vessels around the brain, reducing inflammation and relieving pain. It is available in tablet form and is taken orally. It is usually taken at the first sign of a migraine attack, and can be taken with or without food. It is not recommended for use in children under 18 years of age.
Relpax is a popular choice for migraine sufferers due to its effectiveness and convenience. It is generally well tolerated, with few side effects. Common side effects include nausea, dizziness, and fatigue.
Companies in the Relpax market include Pfizer, Merck, and GlaxoSmithKline. Show Less Read more